See more : Akerna Corp. (KERNW) Income Statement Analysis – Financial Results
Complete financial analysis of Strategic Asset Leasing, Inc. (LEAS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Strategic Asset Leasing, Inc., a leading company in the Rental & Leasing Services industry within the Industrials sector.
You may be interested
- CatchMark Timber Trust, Inc. (CTT) Income Statement Analysis – Financial Results
- Western Acquisition Ventures Corp. (WAVSU) Income Statement Analysis – Financial Results
- Chofu Seisakusho Co., Ltd. (CFSKF) Income Statement Analysis – Financial Results
- Peruvian Metals Corp. (PER.V) Income Statement Analysis – Financial Results
- Arcadis NV (ARCAY) Income Statement Analysis – Financial Results
Strategic Asset Leasing, Inc. (LEAS)
About Strategic Asset Leasing, Inc.
Anew Medical, Inc. focuses on developing biologic medicines for the treatment of cancer, cardiovascular, and neurodegenerative disorders. The company is based in Omaha, Nebraska.
| Metric | 2022 | 2021 | 2020 | 2019 | 1992 | 1991 | 1990 | 1989 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 100.00K | 600.00K | 100.00K | 200.00K |
| Cost of Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 200.00K | 700.00K |
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 100.00K | 600.00K | -100.00K | -500.00K |
| Gross Profit Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 100.00% | 100.00% | -100.00% | -250.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 572.97K | 287.92K | 165.13K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 573.80K | 1.11M | 912.98K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 574.37K | 1.11M | 913.15K | 15.28K | 1.60M | 1.00M | 1.20M | 1.30M |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 574.37K | 1.11M | 913.15K | 15.28K | 1.60M | 1.10M | 1.30M | 1.50M |
| Cost & Expenses | 574.37K | 1.11M | 913.15K | 15.28K | 1.60M | 1.10M | 1.50M | 2.20M |
| Interest Income | 0.00 | 0.00 | 6.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 24.37K | 0.00 | 0.00 | 733.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 228.49K | 236.56K | 206.30K | 171.86K | 0.00 | 100.00K | 100.00K | 200.00K |
| EBITDA | -574.37K | -1.11M | -913.15K | -15.28K | -1.30M | 100.00K | -600.00K | -1.40M |
| EBITDA Ratio | 0.00% | 0.00% | 0.00% | 0.00% | -1,300.00% | 16.67% | -600.00% | -700.00% |
| Operating Income | -574.37K | -1.11M | -913.15K | -15.28K | -1.30M | 0.00 | -700.00K | -1.60M |
| Operating Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | -1,300.00% | 0.00% | -700.00% | -800.00% |
| Total Other Income/Expenses | -24.22K | 45.00 | 6.00 | 24.27K | -200.00K | -500.00K | 0.00 | -400.00K |
| Income Before Tax | -598.59K | -1.11M | -913.14K | 8.99K | -1.50M | 0.00 | -1.40M | -2.00M |
| Income Before Tax Ratio | 0.00% | 0.00% | 0.00% | 0.00% | -1,500.00% | 0.00% | -1,400.00% | -1,000.00% |
| Income Tax Expense | -574.37 | -1.11K | -913.15 | 0.00 | 200.00K | 500.00K | 900.00K | 400.00K |
| Net Income | -598.59K | -1.11M | -913.14K | 8.99K | -1.70M | -1.00M | -2.30M | -2.40M |
| Net Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | -1,700.00% | -166.67% | -2,300.00% | -1,200.00% |
| EPS | 0.00 | -0.01 | 0.00 | 0.00 | 0.00 | -500.00K | -2.30M | -2.40M |
| EPS Diluted | 0.00 | -0.01 | 0.00 | 0.00 | 0.00 | -500.00K | -2.30M | -2.40M |
| Weighted Avg Shares Out | 1.04B | 171.76M | 1.04B | 177.30M | 0.00 | 2.00 | 1.00 | 1.00 |
| Weighted Avg Shares Out (Dil) | 1.04B | 171.76M | 1.04B | 177.30M | 0.00 | 2.00 | 1.00 | 1.00 |
ANEW MEDICAL ANNOUNCES KEY PATENT ISSUED IN CHINA TO PROTECT KLOTHO PROTEIN AND GENE DELIVERY SYSTEMS
NEW YORK , March 4, 2024 /PRNewswire/ -- ANEW MEDICAL, INC. ("ANEW" or "the Company") (OTCPK: LEAS) a US-based biotechnology company ("ANEW") focused on developing cell and gene- based treatments to affect aging and age-related diseases, announced that is has...
ANEW MEDICAL, INC. to Present at the Emerging Growth Conference on Wednesday, 01/11/23
NEW YORK , Jan. 9, 2023 /PRNewswire/ -- ANEW MEDICAL, INC (OTC:LEAS), focused on developing Essential Medicines for Life (ANEW MEDICAL or the "Company") is pleased to announce that it has been invited to present at the Emerging Growth Conference...
Source: https://incomestatements.info
Category: Stock Reports